CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 132 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,426,000 | -63.6% | 90,000 | -54.0% | 1.09% | -47.1% |
Q1 2022 | $6,659,000 | -79.6% | 195,500 | -76.8% | 2.07% | -70.1% |
Q4 2021 | $32,612,000 | -38.5% | 844,000 | -14.3% | 6.92% | -30.2% |
Q3 2021 | $53,045,000 | +61.0% | 985,000 | 0.0% | 9.91% | +81.1% |
Q2 2021 | $32,938,000 | +62.3% | 985,000 | 0.0% | 5.47% | +83.6% |
Q1 2021 | $20,291,000 | +16.7% | 985,000 | -0.7% | 2.98% | +31.3% |
Q4 2020 | $17,380,000 | +18.1% | 992,000 | 0.0% | 2.27% | -21.1% |
Q3 2020 | $14,711,000 | +5.7% | 992,000 | -7.4% | 2.88% | +2.3% |
Q2 2020 | $13,923,000 | – | 1,071,000 | – | 2.81% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |